Showing 6,801 - 6,820 results of 226,904 for search '(( a ((peer decrease) OR (a decrease)) ) OR ( i ((largest decrease) OR (larger decrease)) ))', query time: 1.57s Refine Results
  1. 6801
  2. 6802
  3. 6803
  4. 6804
  5. 6805
  6. 6806
  7. 6807
  8. 6808
  9. 6809

    A 92-year-old female with 80% stenosis of left internal carotid artery received carotid stenting. by Han-Jui Lee (803878)

    Published 2017
    “…<p>(A) Pre-stenting MR perfusion showed decreased cerebral blood flow in the right hemisphere compared to the left hemisphere. …”
  10. 6810

    Fig 9 - by Mamatha Garige (10719830)

    Published 2021
    “…<i>discoideum</i>. (A) <i>D</i>. <i>discoideum</i> cell proliferation was decreased by 60% at the end of 72 hours (doxycycline-induced) <i>gstA2</i>-knockdown cells, whereas (B) overexpression of DdGSTA2 did not significantly affect the proliferation of cells. …”
  11. 6811

    Protein abundance changes with stage in the glycolysis pathway. by Benjamin A. Neely (625157)

    Published 2016
    “…Levels of two proteins, PFKP and PKM, were confirmed using IHC staining of stage I ccRCC tissue (other stages were not evaluated by IHC). A representative IHC image is shown for PFKP and PKM along with average staining intensity (H value) ± standard error of a stage I ccRCC TMA. …”
  12. 6812

    A genetically engineered microRNA-34a prodrug demonstrates anti-tumor activity in a canine model of osteosarcoma by Fernando Alegre (6166193)

    Published 2018
    “…Additionally, our subcutaneous OSA xenograft model demonstrated <i>in vivo</i> tumor growth delay, increased necrosis and apoptosis by tRNA/miR-34a, and decreased cellular proliferation ability. …”
  13. 6813

    <i>DAPK1</i> Promoter Methylation and Cervical Cancer Risk: A Systematic Review and a Meta-Analysis by Antonella Agodi (638417)

    Published 2015
    “…The aim of the present study was to carry out a systematic review and a meta-analysis in order to evaluate <i>DAPK1</i> promoter methylation as an epigenetic marker for CC risk.…”
  14. 6814

    Simplified overview of molecular signalling after sprint exercise. by Hakan Claes Rundqvist (7541837)

    Published 2019
    “…<p>A selection of stimuli (green–increased and blue—decreased), signalling pathways (red–upregulated and blue–downregulated and downstream biofunctions (yellow) are presented. …”
  15. 6815

    HHV-6A infection increases glucose metabolism and glycolysis in HSB-2 cells. by Zhisheng Wu (1540864)

    Published 2020
    “…**p < 0.01, compared with mock infection groups. <b>(C)</b> HHV-6A infection decreased glucose levels in the culture medium of in HSB-2 cells. …”
  16. 6816

    Information details: cyclin A2 and PHH3 expression. by James W. Jacobberger (184625)

    Published 2012
    “…A: brackets show are of cyclin A2 decrease in early mitosis; small arrow points to “new born” cells; large arrow points to large cluster in early mitosis, largely composes of prophase cells. …”
  17. 6817

    Pre-incubation of SB105-A10 either with HIV-1<sub>IIIb</sub> or HIV-1<sub>ada</sub> strains inhibits the viral infectivity in dilution assay. by Isabella Bon (467395)

    Published 2013
    “…<p>HIV-1 strains were incubated for 1 hour at 37°C with SB105-A10 (20 µg/ml; 4.2 µM). Following this incubation the samples were diluted 50-fold to reduce dendrimer concentrations to a level below that at which SB105-A10 significantly inhibits HIV replication and challenged with activated PBMCs. …”
  18. 6818

    T Cell Leukemia/Lymphoma 1A is essential for mouse epidermal keratinocytes proliferation promoted by insulin-like growth factor 1 by Antonella Bresin (5819432)

    Published 2018
    “…Finally, we found TCL1 to act, at least in part, via increasing phospho-ERK1/2 and decreasing phospho-P38 MAPK. Hence, our data demonstrate that regulated levels of <i>Tcl1a</i> are necessary for the correct proliferation and differentiation of the interfollicular KCs.…”
  19. 6819

    <i>LDLR</i> and <i>PCSK9</i> Are Associated with the Presence of Antiphospholipid Antibodies and the Development of Thrombosis in aPLA Carriers by Eguzkine Ochoa (429972)

    Published 2016
    “…Expression level study showed significantly decreased expression level of <i>LDLR</i> gene in aPLA carriers (<i>P</i>-value <0.0001; 95%CI 0.16–2.10; SE 0.38–1.27) in comparison to the control group.…”
  20. 6820